Literature DB >> 10817704

Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.

D L Williams1, L Spring, E Harris, P Roche, T P Gillis.   

Abstract

Two Mycobacterium leprae genes, folP1 and folP2, encoding putative dihydropteroate synthases (DHPS), were studied for enzymatic activity and for the presence of mutations associated with dapsone resistance. Each gene was cloned and expressed in a folP knockout mutant of Escherichia coli (C600DeltafolP::Km(r)). Expression of M. leprae folP1 in C600DeltafolP::Km(r) conferred growth on a folate-deficient medium, and bacterial lysates exhibited DHPS activity. This recombinant displayed a 256-fold-greater sensitivity to dapsone (measured by the MIC) than wild-type E. coli C600, and 50-fold less dapsone was required to block (expressed as the 50% inhibitory concentration [IC(50)]) the DHPS activity of this recombinant. When the folP1 genes of several dapsone-resistant M. leprae clinical isolates were sequenced, two missense mutations were identified. One mutation occurred at codon 53, substituting an isoleucine for a threonine residue (T53I) in the DHPS-1, and a second mutation occurred in codon 55, substituting an arginine for a proline residue (P55R). Transformation of the C600DeltafolP::Km(r) knockout with plasmids carrying either the T53I or the P55R mutant allele did not substantially alter the DHPS activity compared to levels produced by recombinants containing wild-type M. leprae folP1. However, both mutations increased dapsone resistance, with P55R having the greatest affect on dapsone resistance by increasing the MIC 64-fold and the IC(50) 68-fold. These results prove that the folP1 of M. leprae encodes a functional DHPS and that mutations within this gene are associated with the development of dapsone resistance in clinical isolates of M. leprae. Transformants created with M. leprae folP2 did not confer growth on the C600DeltafolP::Km(r) knockout strain, and DNA sequences of folP2 from dapsone-susceptible and -resistant M. leprae strains were identical, indicating that this gene does not encode a functional DHPS and is not involved in dapsone resistance in M. leprae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817704      PMCID: PMC89908          DOI: 10.1128/AAC.44.6.1530-1537.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The PROSITE database, its status in 1999.

Authors:  K Hofmann; P Bucher; L Falquet; A Bairoch
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

3.  Dapsone-resistant leprosy in Ethiopia.

Authors:  J M Pearson; G S Haile; R S Barnetson; R J Rees
Journal:  Lepr Rev       Date:  1979-09       Impact factor: 0.537

Review 4.  Drug resistance in leprosy--a review.

Authors:  B H Ji
Journal:  Lepr Rev       Date:  1985-12       Impact factor: 0.537

5.  Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme.

Authors:  P Lopez; M Espinosa; B Greenberg; S A Lacks
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

6.  Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.

Authors:  T P Gillis; D L Williams
Journal:  Indian J Lepr       Date:  1999 Jan-Mar

7.  An apparent Bacillus subtilis folic acid biosynthetic operon containing pab, an amphibolic trpG gene, a third gene required for synthesis of para-aminobenzoic acid, and the dihydropteroate synthase gene.

Authors:  J Slock; D P Stahly; C Y Han; E W Six; I P Crawford
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

8.  Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.

Authors:  M Kai; M Matsuoka; N Nakata; S Maeda; M Gidoh; Y Maeda; K Hashimoto; K Kobayashi; Y Kashiwabara
Journal:  FEMS Microbiol Lett       Date:  1999-08-15       Impact factor: 2.742

9.  Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis.

Authors:  R Manganelli; E Dubnau; S Tyagi; F R Kramer; I Smith
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

10.  Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).

Authors:  J K Seydel; M Richter; E Wempe
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-03
View more
  23 in total

1.  Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.

Authors:  Wei Li; Masanori Matsuoka; Masanori Kai; Pratibha Thapa; Saraswoti Khadge; Deanna A Hagge; Patrick J Brennan; Varalakshmi Vissa
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.

Authors:  Gabriela Schneider-Rauber; Debora Fretes Argenta; Thiago Caon
Journal:  Pharm Res       Date:  2020-11-09       Impact factor: 4.200

4.  Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.

Authors:  Niranjan Prakash Mahajan; Mallika Lavania; Itu Singh; Saraswati Nashi; Veeramani Preethish-Kumar; Seena Vengalil; Kiran Polavarapu; Chevula Pradeep-Chandra-Reddy; Muddasu Keerthipriya; Anita Mahadevan; Tagaduru Chickabasaviah Yasha; Bevinahalli Nanjegowda Nandeesh; Krishnamurthy Gnanakumar; Gareth J Parry; Utpal Sengupta; Atchayaram Nalini
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

5.  Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.

Authors:  Kazumasa Yokoyama; Hyun Kim; Tetsu Mukai; Masanori Matsuoka; Chie Nakajima; Yasuhiko Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

6.  Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.

Authors:  D L Williams; T L Pittman; T P Gillis; M Matsuoka; Y Kashiwabara
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.

Authors:  H Mehta; J Weng; A Prater; R A L Elworth; X Han; Y Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

8.  Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.

Authors:  Wei Li; Rama M Sakamuri; Danielle E Lyons; Florenda M Orcullo; Vidyagouri Shinde; Edred Lao Dela Pena; Armi A Maghanoy; Irene B Mallari; Esterlina V Tan; Indira Nath; Patrick J Brennan; Marivic Balagon; Varalakshmi Vissa
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

Review 9.  Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Authors:  Pushpendra Singh; Stewart T Cole
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

10.  Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.

Authors:  Noboru Nakata; Masanori Kai; Masahiko Makino
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.